Overview

The equity portfolio invests in the 100 largest Swiss companies by market capitalisation.

Investments on the Swiss stock market

Benefits

Easy access to the Swiss stock market.

The fund offers investors broad diversification.

Risks

UBS Country & Regional Funds invest in equities and may therefore be subject to high fluctuations in value. All investments are subject to market fluctuations. Every fund has specific risks, which can significantly increase under unusual market conditions. The fund can use derivatives, which may result in additional risks (particularly counterparty risk).All investments are subject to market fluctuations. Every fund has specific risks, which can significantly increase under unusual market conditions. Please consult your client advisor for more information on the investment risks of this product.

Features

Product category
Equity
Europe
Product domicile
Switzerland
Portfolio management
UBS SA国际传谋 Switzerland AG, Zurich
Fund management
UBS Fund Management (Switzerland) AG
Custodian bank
UBS Switzerland AG, Zurich
Day of inception
June 5, 2014
Currency of account
CHF
Close of financial year
October 31
SFDR Classification
n.a.
Issue / redemption
daily
Maturity
Open end
Ongoing costs p.a.
0.20% p.a.
Flat fee
0.19% p.a.
Management fee
0.15% p.a.
Total expense ratio (TER)
0.20% p.a.
Minimum investment
n.a.
Reference Index / Benchmark
UBS 100 Index (net div. reinv.)
Cut-Off Time
13:30h(CET)
Securities no.
20551640
ISIN
CH0205516401
Bloomberg Ticker
UBSIA1C SW
Telekurs Id
SIND1

Performance and Prices

Percentage growth

as of April 23, 2026
Cumulative
CHF(%) EUR(%) USD(%)
YTD 2.62 4.00 3.58
1M
3M
6M
1Y
2Y 17.47 18.87 34.65
3Y
5Y 28.80 55.05 50.70
ø p.a.5Y 5.19 9.17 8.55

Current data
Net asset value 23.04.2026 CHF 165.32
High - last 12 months 27.02.2026 CHF 170.25
Low - last 12 months 24.04.2025 CHF 146.45
Last distribution 16.01.2026 CHF 3.75
Assets of the unit class in mn 23.04.2026 CHF 1.73
Total product assets in mn 23.04.2026 CHF 2,408.74
Statistical data
Date
2 years
5 years
Total risk reference index / benchmark 31.03.2026 11.83% 12.38%
Sharpe Ratio 31.03.2026 0.58 0.36
Risk Free Rate 31.03.2026 0.46% 0.40%

Structures

By the 10 largest equity positions (in %, as of March 31, 2026)

 
 
Novartis AG 14.28
Roche Holding AG 13.88
Nestle SA 12.16
ABB Ltd 6.01
UBS Group AG 5.67
Zurich Insurance Group AG 5.19
Cie Financiere Richemont SA 4.48
Swiss Re AG 2.38
Lonza Group AG 2.13
Holcim AG 2.09

Fees

Ongoing costs p.a.
0.1952%
Flat fee
0.1900%
Management fee p.a.
0.1500%

Distributions

From
01-Nov-2020
To
01-Nov-2021
Date of distribution
Pay date
Cps no.
Currency
Tax domicile CH gross amount
Tax domicile CH net amount
Tax domicile not CH gross amount
Tax domicile not CH net amount
14.01.2026 16.01.2026 12 CHF 3.75 2.44 3.75 2.44

Sales Authorisations

Market
Sales authorisations status
Singapore
Institutional Only*
Switzerland
Registered

Literature

en
de
fr
it
es
Brochures
Document type
Document Language
Fact Sheet
de de
it it
fr fr
es es
en en
Swiss Climate Scores Report
ASIP ESG Report
Fact Sheet - Equity
de de
en en
es es
fr fr
it it
Fact Sheet - Europe
es es
fr fr
it it
de de
en en
Agreement / Prospectus
Document type
Document Language
Prospectus
Key Information Document
Past performance
Previous performance scenario
Annual and semi-annual report (accounting on October 31)
Document type
Document Language
Annual report
Semi-annual report
Please wait for the requested content to load. If there is no response after several minutes, please reload the page or try again later.